Sign in
Taking people in United KingdomNo phase

Combined talk therapy for adults with obsessive-compulsive disorder and tics

Tests a combined talk therapy for adults with obsessive-compulsive disorder and tics.

Key facts

Who runs it
University College London Hospitals
Where
London, United KingdomSee the 2 sites
Trial code
Registry title
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Status
Recruiting
People taking part
40 people, planned
Started
8 Jul 2026
Expected to end
1 Feb 2030
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Exposure and Response Prevention (ERP)
  • Habit Reversal Training (HbRT
  • Psychoeducation and Supportive Intervention
Record updated
27 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with a Tourettic type of OCD, meaning they have both obsessive-compulsive symptoms and tics. It compares talking therapies for these symptoms.

Age
18 Years to 65 Years
Sex
All genders can join.
Disease stage
A main diagnosis of a tic disorder (such as Tourette syndrome, or a chronic, provisional or other tic disorder) or of obsessive-compulsive disorder (OCD). A score of at least 16 on the YBOCS and at least 5 on the Premonitory Urge for Tics Scale (PUTS) is needed.
Earlier treatment
People taking medicines for mental health can join if the type and dose stay the same during the therapy period.

Main reasons for not taking part

  • Substance misuse
  • Current personality disorder, schizophrenia or bipolar disorder
  • Active thoughts of suicide
  • Needing an interpreter
  • Other mental health or nerve conditions that the study team thinks would affect taking part or the results

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Age 18 years or older
  • All genders
  • Confirmation of a primary diagnosis of either:
  • Tourettes Disorder / Tourette Syndrome b. Persistent Motor or Vocal Tic Disorder / Chronic Motor or Vocal Tic Disorder c. Provisional Tic Disorder / Transient Motor Tics d. Other Specified Tic Disorder e. Unspecified Tic Disorder f. Obsessive-Compulsive Disorder [d] Participants taking psychotropic medication are eligible provided medication type and dose remain stable throughout the intervention period [e] Ability to provide sustained informed consent [f] A minimum score of 16 on YBOCS [g] A minimum score of 5 on the Premonitory Urge for Tics Scale (PUTS)

Who cannot take part

  • Current diagnosis of a personality disorder
  • Bipolar disorder
  • Any psychiatric or neurological condition that, in the opinion of the investigators, would interfere with participation or interpretation of study outcomes
  • Substance misuse
  • Schizophrenia
  • Contraindications to participation in a trial (i.e., active suicidal ideations and/or requirement of an interpreter)

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United Kingdom

  • University College London Hospitals NHS Foundation TrustLondon, United KingdomContact: Dipesh Patel, MPhil / PhDTaking people
  • University College London Queen Square Institute of NeurologyLondon, United KingdomContact: Dipesh Patel, MPhil / PhDTaking people

About the trial

What the trial wants to find out

Obsessive-Compulsive Disorder and Tic Disorders frequently co-occur, and a subgroup of patients - those with a Tourettic Subtype of OCD (TOCD) - present with concurrent obsessive-compulsive and tic symptoms. Existing psychological interventions typically target one condition or the other, but rarely both together. This study aims to test whether a combined psychological therapy integrating Exposure and Response Prevention (ERP) and Habit Reversal (HbRT) is more effective at reducing symptoms than either therapy delivered alone, in adults with TOCD.

The 4 groups in the trial

  • Combined Exposure and Response Prevention and Habit ReversalTreatment being tested

    Participants allocated to this arm will receive a 12-week individual psychological intervention integrating Exposure and Response Prevention (ERP) and Habit Reversal Training (HRT). ERP will involve planned exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while reducing compulsions, avoidance, reassurance seeking, and other safety behaviours. HRT will include awareness training, identification of premonitory urges and tic-related cues, development and practice of competing responses, and strategies to support generalisation. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

    Treatment: Exposure and Response Prevention (ERP) and Habit Reversal Training (HbRT

  • Standardised Exposure and Response PreventionExisting treatment, for comparison

    Participants allocated to this arm will receive a 12-week individual psychological intervention based on Exposure and Response Prevention (ERP). Treatment will involve gradual and systematic exposure to obsessional fears, distress, sensory discomfort, premonitory urges, and "not-just-right" experiences while refraining from compulsions, avoidance, reassurance seeking, and other safety behaviours. The intervention aims to reduce obsessive-compulsive symptoms by promoting inhibitory learning and increasing tolerance of uncertainty and internal experiences. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

    Treatment: Exposure and Response Prevention (ERP)

  • Standardised Habit ReversalExisting treatment, for comparison

    Participants allocated to this arm will receive a 12-week individual psychological intervention based on Habit Reversal Training (HbRT). Treatment will include awareness training to improve recognition of tics and premonitory urges, identification of antecedents and contextual triggers, development and practice of competing responses, and strategies to promote generalisation of skills to everyday settings. The intervention aims to reduce tic severity and improve voluntary tic management. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

    Treatment: Habit Reversal Training (HbRT

  • Psychoeducation / Supportive InterventionExisting treatment, for comparison

    Participants allocated to this arm will receive a 12-week individual psychological intervention consisting of psychoeducation and supportive therapy. Sessions will provide information about obsessive-compulsive disorder, tic disorders, Tourettic obsessive-compulsive disorder, stress, and wellbeing, together with supportive discussion and general problem-solving. This intervention will not include structured Exposure and Response Prevention, Habit Reversal Training, or other targeted behavioural techniques. Sessions will last approximately 50 minutes and will be delivered face-to-face or remotely.

    Treatment: Psychoeducation and Supportive Intervention

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Integrating Exposure and Response Prevention and Habit Reversal Techniques to Treat a Tourettic Subtype of Obsessive-Compulsive Disorder (Tourettic OCD)
Plain-language title
Combined talk therapy for adults with obsessive-compulsive disorder and ticsGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT07725926, who can take part
Record updated
27 July 2026